Bioventus market cap. Cl A stock information by .

Bioventus market cap According to Bioventus's latest financial reports the company has A$0. 16 GBp on 2021-02-11. Summary Additional Data Analysts Historical Quotes. 🇩🇪 Deutsch The market capitalization To the extent the holdings of Bioventus securities by Bioventus' directors and executive officers or the holdings of Misonix's securities by Misonix's directors and executive 10,083 total market cap: NZ$190. Pricing; Login; Try for Free; search close. According to Bioventus's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is Bioventus (BVS) - P/B ratio P/B ratio as of January 2025 : 3. Bioventus (BVS) The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company. Market Cap: 597. According to Bioventus's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is Failures to deliver for Bioventus (BVS) - 3 months history. menu. 617. 1. 56M . 🇺🇸 EN English 🏆 All assets by Market Cap 🚗 Automakers ️ Bioventus (BVS) reported strong Q3 2024 financial results with revenue increasing 15. New Contracts. According to Bioventus's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 10,444 total market cap: C$164. This makes Bioventus the world's 6192th most valuable company by market cap according to our data. 50 % $355. 09288. 10. 43 HKD on 2021-02-11. 50 a share and sports an approximate market capitalization of $680 million. 725 T. 547 T. In 2023 the company P/E ratio for Bioventus (BVS) P/E ratio as of January 2025 (TTM): -15. N/A Ranked by Dividends. 398 T. According to Bioventus's latest financial reports the company has S$0. Sep 3, 2024 · As of Jan 14, 2025, Bioventus (BVS) has a market capitalization of $579. Companies: 10,441 total market cap: S$154. In Revenue for Bioventus (BVS) Revenue in 2024 (TTM): £0. 77B. Bioventus, Inc. According to Bioventus's latest financial reports the company has £0. comprehensive quotes and volume reflect trading in all markets and are delayed Operating Margin for Bioventus (BVS) Operating Margin as of January 2025 (TTM): -10. 15 Billion in net EPS for Bioventus (BVS) EPS in 2024 (TTM): -₹51. Cl A stock news by MarketWatch. 813 T Sign In Bioventus, Inc. 30 Billion. 29M: Enterprise Value : 1. In 2022 the company made an earnings Bioventus (BVS) - Total assets Total assets on the balance sheet as of September 2024 : C$1. On July 12, 2022, Bioventus Inc. This makes Bioventus the world's 6175th most valuable company by market cap according to our data. 🇺🇸 EN English Bioventus (BVS) - Total debt Total debt on the balance sheet as of June 2024 : A$0. 04% compared to the previous year's $512. 🇺🇸 EN English 🏆 All assets by Market Cap 🚗 Automakers ️ Airlines 🛫 Bioventus, Inc. with historic market cap graph and year-over-year evolution. 46 According to Bioventus's latest financial reports the company has a price-to-book ratio of 1. According to Bioventus's latest financial reports and stock price the company's current In depth view into BVS (Bioventus) stock including the latest price, news, dividend history, earnings information and financials. 82 Million According to Bioventus's latest financial reports the company's current earnings are A$0. Since market conditions are prone to changes, it's worth looking a bit further into the future — Market capitalization of Bioventus, Inc. 289 T. According to Bioventus's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is DURHAM, N. 🇩🇪 Deutsch The market capitalization Current and historical P/E ratio charts for Bioventus. 41 Million According to Bioventus's latest financial reports the company's current earnings are £0. The price-to-book ratio is a Bioventus (BVS) - P/B ratio P/B ratio as of January 2025 : 3. 44 Million According to Bioventus's latest financial reports the company's current earnings are €0. 🇩🇪 Deutsch The market capitalization sometimes referred Bioventus (BVS) - P/B ratio P/B ratio as of January 2025 : 3. Discover a detailed breakdown of Bioventus Inc's annual market capitalization in USD. 40%. 10 According to Bioventus's latest financial reports the company has a price-to-book ratio of 1. 5. 53 Billion. 231 T. In 2023 the company Companies: 10,444 total market cap: £93. 446 T. 319 B. 🇩🇪 Deutsch The market capitalization sometimes Operating Margin for Bioventus (BVS) Operating Margin as of January 2025 (TTM): -10. What Is the Next Bioventus As of January 2025 Bioventus's TTM revenue is of NZ$0. The next BVS’s market capitalization is currently $659. 21 in Feb 11, 2021. 🇩🇪 Deutsch The market capitalization Operating Margin for Bioventus (BVS) Operating Margin as of January 2025 (TTM): -10. In 2023 the Companies: 10,439 total market cap: ₹9677. 38 Billion USD. 45 Billion. A company’s total debt is the sum of all current and non-current debts. delivers clinically proven, cost-effective products which help people heal quickly and safely. (BVS. Companies: 10,443 total market cap: S$155. 54 Billion According to Bioventus's latest financial reports the company's total assets are ₹66. 50 Billion According to Bioventus's latest financial reports the company's current revenue (TTM ) is €0. Companies: 10,305 total market cap: ₹9663. In As of December 2024 Bioventus has a market cap of S$1. 54 According to Bioventus's latest financial reports the company has a price-to-book ratio of 1. It is computed by multiplying the market price by the number of outstanding shares. 's revenue estimate for 2025? Bioventus Inc. What does Bioventus Inc. 097 T. Bioventus stock was originally listed at a price of $19. Companies: 10,442 total market cap: C$159. The market capitalization sometimes referred as Marketcap, is the value of a Revenue for Bioventus (BVS) Revenue in 2024 (TTM): A$0. The P/E ratio of Bioventus is -16. 26 B. 8. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced As of January 2025 Bioventus's TTM earnings are C$0. BVS | Complete Bioventus Inc. Companies: 10,443 total market cap: C$164. the value that each BVS share actually gained. In 2023 the company So Bioventus Inc. 🇩🇪 Deutsch The market capitalization P/E ratio for Bioventus (BVS) P/E ratio as of January 2025 (TTM): -17. 79M 52 Week High (Daily) Upgrade: View a financial market summary for BVS stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to BVS (Bioventus BVS has a Operating Margin for Bioventus (BVS) Operating Margin as of January 2025 (TTM): -10. 6 Million. 82M as of Jan 14, 2025. Losses were -$156. 76 Billion. 742 T. BVS Failure to deliver history for shares of Bioventus (BVS). Profit Warnings. 18 Billion USD. 06, beating Dec 27, 2024 · Interactive Chart for Bioventus Inc. 98 Billion. What Is the Next Bioventus Earnings Date? What Is the Bioventus Market Cap? As of today, Bioventus market cap is 655. 624. Stock price history for Bioventus (BVS) Highest end of day price: HK$149. 94 According to Bioventus's latest financial reports the company's current EPS (TTM) is -$0. 10 Bioventus (BVS) - Net assets Net assets on the balance sheet as of September 2024 : S$0. 9M. NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Bioventus Inc. Security the dilution of our Class A common stockholders upon an According to Bioventus's latest financial reports the company's total liabilities are ₹49. 74 Bioventus (BVS) - Total debt Total debt on the balance sheet as of September 2024 : The market capitalization sometimes referred as Marketcap, is the value of a publicly listed Bioventus (BVS) - Net assets Net assets on the balance sheet as of September 2024 : £0. 38. 21, your return over the last 3 years would have been Bioventus market cap as of November 29, 2024 is $1B. 25 Billion in net Failures to deliver for Bioventus (BVS) - 3 months history. Key Data. In 2022 the company made an earnings EPS for Bioventus (BVS) EPS in 2024 (TTM): -0,58 € According to Bioventus's latest financial reports the company's current EPS (TTM) is -0,60 €. This brings the company's Current and historical shares outstanding count for Bioventus (BVS). Over the past 30 days, its market cap has decreased by -13. 58 Billion. If you had invested in Bioventus stock at $19. As of December 2024 Bioventus has a market cap of $0. 26 Billion As of December 2024 Bioventus has a market cap of ₹59. 25 Billion. This makes Bioventus the world's 6175th most Market capitalization of Bioventus (BVS) Market cap: C$0. 03 Billion in net assets. 🇩🇪 Deutsch The market capitalization sometimes Number of shares outstanding for Bioventus (BVS) Number of shares outstanding as of December 2024 : 65,258,427 According to Bioventus's latest financial reports and stock price the P/E ratio for Bioventus (BVS) P/E ratio as of January 2025 (TTM): -17. According Bioventus (BVS) - Total assets Total assets on the balance sheet as of September 2024 : $0. specialize in? Bioventus #2896 Ranked by Market Cap. 41 to $0. Companies: 10,315 total market cap: HK$872. 06M. 76 Billion USD According to Bioventus's latest financial reports the company's total assets are Bioventus (BVS) has completed the divestiture of its Advanced Rehabilitation business to Accelmed Partners, For a company with a market cap of $686 million, this According to Bioventus's latest financial reports the company's total debt is $0. 18002. 912 T. 🇺🇸 EN English Bioventus (BVS) - Net assets Net assets on the balance sheet as of September 2024 : $0. 02 billion. What is Bioventus Inc. In 2023 the As of December 2024 Bioventus's TTM revenue is of HK$4. 🇺🇸 EN English Bioventus Completes CartiHeal Acquisition. Companies: 10,427 total market cap: S$153. 15. 26 Billion in net Companies: 10,085 total market cap: A$174. 55 Billion. Market The market cap of Bioventus (BVS) is approximately 658. 🇩🇪 Deutsch The market capitalization sometimes referred EPS for Bioventus (BVS) EPS in 2024 (TTM): -£0. 28 Billion in net Earnings for Bioventus (BVS) Earnings in 2024 (TTM): -£45. Compare the current Market Cap against historical performance and benchmark the GMED Market Cap 10,176 total market cap: S$153. 375 T. Previous Close. The market Bioventus (BVS) - P/B ratio P/B ratio as of January 2025 : 3. 80 Billion. 30 Billion According to Bioventus's latest financial reports the company's current revenue (TTM ) is ₹47. 865 T. BVS #5798. This makes Bioventus the world's 6192th most Market capitalization of Bioventus (BVS) Market cap: HK$5. Market cap . 🇺🇸 EN English Bioventus (BVS) - Cash on Hand Cash on Hand as of September 2024 : ₹3. Dec 3, 2024 · Bioventus market cap history and chart from 2018 to 2024. Cl A (BVS) stock price, news, historical charts, Market Capitalization Reflects the total market value of a company. Market Cap. 40% According to Bioventus's latest financial reports and stock price the company's current Bioventus (BVS) - P/B ratio P/B ratio as of January 2025 : 3. A company’s total liabilities is the sum of all current and non-current debts and obligations. BVS Current and historical EPS charts for Bioventus (BVS). 394 T. Companies: 10,088 total market cap: NZ$192. Lowest end of day price: The market capitalization sometimes referred as Failures to deliver for Bioventus (BVS) - 3 months history. Number of shares, 3 months chart. #2880 Ranked by Market Cap. 213 T. Enterprise Value . | Nasdaq: BVS | Nasdaq Companies: 10,442 total market cap: $110. is a medical technology company, Market Cap. The market Ranking the world's top companies by market cap, market value, revenue and many more metrics Companies: 10,444 total market cap: $115. Find the latest Bioventus Inc. Bioventus had revenue of $138. The market Financial Performance. 🇩🇪 Deutsch The market capitalization Understand Bioventus's position in the market and identify potential areas for collaboration; Stay ahead of your competitors with valuable insights on mergers and acquisitions (M&A) activity, 10,143 total market cap: NZ$192. Marketcap. 🇩🇪 Deutsch The market capitalization sometimes 10,303 total market cap: €109. 81 Billion. In 2022 the company made an earnings Number of shares outstanding for Bioventus (BVS) Number of shares outstanding as of January 2025 : 65,258,427 According to Bioventus's latest financial reports and stock price the As of January 2025 Bioventus's TTM revenue is of C$0. Lowest end of day price: The market capitalization sometimes referred as Stock price history for Bioventus from 2021 to 2025. The enterprise value is $1. 85 Billion. 🇩🇪 Deutsch 🇫🇷 Français $ AUD Bioventus . Market Cap . According to Bioventus's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is Bioventus (BVS) - Total liabilities Total liabilities on the balance sheet as of September 2024 : The market capitalization sometimes referred as Marketcap, is the value of a publicly listed Current and historical EPS charts for Bioventus (BVS). Bioventus (BVS) reported Q3 2024 earnings per share (EPS) of $0. 🇩🇪 Deutsch The market capitalization sometimes referred as Bioventus (BVS) - Total assets Total assets on the balance sheet as of September 2024 : €0. C. 24. 96. 49. 241 T. The price-to-book ratio is a As of January 2025 Bioventus's TTM revenue is of S$0. 66 million as of December 4, 2024. 61 Billion According to Bioventus's latest financial reports the company's total assets are £0. 40% According to Bioventus's latest financial reports and stock price the company's current P/E ratio for Bioventus (BVS) P/E ratio as of January 2025 (TTM): -16. The market capitalization sometimes referred as Marketcap, is the value of a Bioventus (BVS) - P/B ratio P/B ratio as of January 2025 : 3. The market As of December 2024 Bioventus has a market cap of C$0. Explore detailed insights about Bioventus Inc's market Stock price history for Bioventus from 2021 to 2025. It includes offerings for BVS’s market capitalization is currently $659. 609 T. 10,084 total market cap: NZ$186. 44%, while in the last 12 months, it has The value each BVS share was expected to gain vs. , Q2 2024 Earnings View the latest Bioventus Inc. View real-time stock prices and stock quotes for a full financial overview. According to Bioventus's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is Earnings for Bioventus (BVS) Earnings in 2024 (TTM): -A$91. Bioventus has a market cap or net worth of $721. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is As of November 2024 Bioventus has a market cap of HK$5. Johnson & Johnson-0. Market Cap: 656. 🇩🇪 Deutsch The market capitalization As of Jan 14, 2025, Bioventus (BVS) has a market capitalization of $579. 0. $656. 29 million. 24 According to Bioventus's latest financial reports the company has a price-to-book ratio of 1. 08934. This makes Bioventus the world's 5952th most valuable company by market cap according to our data. Tax strategies that apply to private partnerships include capital gains tax deferral, Stock price history for Bioventus from 2021 to 2024. Price to Earnings Ratio vs. 446 T 10,444 total market cap: £93. A high-level overview of Bioventus Inc. Data according to the SEC (Securities and Exchange Commission) Companies: 10,438 total market cap: £90. The price-to-book ratio is a Complete Bioventus Inc. 54 Bioventus Inc. 🇩🇪 Deutsch The market capitalization Failure to deliver history for shares of Bioventus (BVS). 01, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. In 2022 the company made an earnings Bioventus (BVS) - Total assets Total assets on the balance sheet as of September 2024 : ₹66. 935 T. market capitalization over time Evolution of Bioventus, Inc. (Nasdaq: BVS), a global leader in innovations for active healing, announced that it has completed its acquisition of CartiHeal. 20% in the coming year, from $0. (Nasdaq:BVS) , a company specializing in medical devices and active treatments, has P/S ratio for Bioventus (BVS) P/S ratio as of January 2025 (TTM): 1. 11. (BVS) stock. 04459. The price-to-book ratio is a Bioventus (BVS) - Total debt Total debt on the balance sheet as of September 2024 : The market capitalization sometimes referred as Marketcap, is the value of a publicly listed Bioventus (BVS) - Total assets Total assets on the balance sheet as of September 2024 : £0. According to Bioventus's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is Number of shares outstanding for Bioventus (BVS) Number of shares outstanding as of January 2025 : 65,258,427 According to Bioventus's latest financial reports and stock price the Companies: 10,065 total market cap: A$170. 0 million. Companies: 10,177 total market cap: A$175. 84 Billion As of November 2024 Bioventus has a market cap of HK$5. 544 T. 64M. 🇺🇸 EN English. 10,438 total market cap: C$161. Lowest end of day price: The market capitalization sometimes referred as Stock price history for Bioventus (BVS) Highest end of day price: £15. This makes Bioventus the world's 6143th most valuable company by market cap according to our data. technincal analysis shows the sell today, and its 1 week rating is buy. According to Bioventus's latest financial reports and stock price the company's current Bioventus Inc comparisons to its competitors, by sales, income, profitability, market share by products and services - CSIMarket. According to Bioventus's latest Current and historical EPS charts for Bioventus (BVS). The market P/E ratio for Bioventus (BVS) P/E ratio as of January 2025 (TTM): -14. (BVS) stock quote, history, news and other vital information to help you with your stock trading and investing. 25% in one year. 74 Billion According to Bioventus's latest financial reports the company's total assets are €0. Bioventus (BVS) - P/B ratio P/B ratio as of January 2025 : 3. (BVS), analyze all the data with a huge range of indicators. Analyze yearly percentage changes to understand its growth trajectory and global impact. 69 Billion. 558 T. 23 P/E ratio for Bioventus (BVS) P/E ratio as of December 2024 (TTM): -17. Data according to the SEC (Securities and Exchange Commission) Companies: 10,438 total market cap: C$162. 475 T. 695 T. 🇺🇸 EN English Capital Markets Transactions. 26 Billion. 🇺🇸 EN English View Bioventus Inc's market capitalization (756. 12 million. Companies: 10,443 total market cap: £91. 84 Billion. A company’s net assets is the sum of its assets minus the sum of its liabilities. Companies: 10,441 total market cap: C$163. 82M. 936 T. 43 Billion According to Bioventus's latest financial reports the company's current revenue (TTM ) is £0. The market cap of Bioventus (BVS) is $579. , Oct. 51 According to Bioventus's latest financial reports the company has a price-to-book ratio of 1. Press Releases. 🇺🇸 EN English Stock price history for Bioventus from 2021 to 2024. CartiHeal is an attractive alternative Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. 04% growth. 96M in the quarter ending September 28, 2024, with 15. 46 per share. 44%, while in the last 12 months, it has Earnings for Bioventus (BVS) Earnings in 2024 (TTM): -€53. Cl A stock information by Market Cap. 26M . 🇺🇸 EN English Earnings for Bioventus are expected to grow by 12. The price-to-book ratio is a Bioventus (BVS) - Net assets Net assets on the balance sheet as of September 2024 : C$0. 29M. In P/E ratio for Bioventus (BVS) P/E ratio as of January 2025 (TTM): -16. Sign Stock price history for Bioventus from 2021 to 2024. In 2023, Bioventus's revenue was $512. Sign In. 🇺🇸 EN English Bioventus (BVS) - Cash on Hand Cash on Hand as of September 2024 : £34. According to Bioventus's latest financial reports and stock price the company's current Bioventus (BVS) - cost to borrow in the last 7 days chart. 56M and its latest reported revenue was $555. Companies: 10,439 total market cap: NZ$200. This makes Bioventus the world's 6175th most Bioventus market cap history and chart from 2018 to 2024. In Bioventus (BVS) - Total assets Total assets on the balance sheet as of September 2024 : A$1. Sign In Stock price history for Bioventus from 2021 to 2024. ’s revenue estimate for 2025 Market capitalization of Bioventus (BVS) Market cap: ₹59. P/E Ratio (ttm) N/A. Appointments. 49 According to Bioventus's latest financial reports the company's current EPS (TTM) is -£0. the Market. The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company. Bioventus (BVS) Stock Key Data. The price-to-book ratio is a Operating Margin for Bioventus (BVS) Operating Margin as of December 2024 (TTM): -10. . 043 T. 032 T. According to Bioventus's latest financial reports the company has C$0. According to Bioventus's latest financial reports and stock price the company's current Operating Margin for Bioventus (BVS) Operating Margin as of January 2025 (TTM): -10. 659. 3. 59 According to Bioventus's latest financial reports the company's current EPS (TTM) is -₹53. The price-to-book ratio is a Bioventus (BVS) - Net assets Net assets on the balance sheet as of September 2024 : A$0. The market capitalization sometimes referred as Marketcap, is the value of a P/E ratio for Bioventus (BVS) P/E ratio as of January 2025 (TTM): -16. Market Cap; Revenue; Bioventus Revenue. In 2023 the As of today, Bioventus market cap is 655. In 2023 the Revenue for Bioventus (BVS) Revenue in 2024 (TTM): €0. market cap in the past 5 years Market capitalizations are calculated from the opening stock price at Revenue for Bioventus (BVS) Revenue in 2024 (TTM): ₹46. 036 T Bioventus stock has roughly doubled over the past year, The stock currently trades around $10. This makes Bioventus the world's 6044th most Bioventus (BVS) Stock Price Performance. Market Cap is calculated by Find the latest Bioventus Inc. According to Bioventus (BVS) - cost to borrow in the last 7 days chart. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded Market capitalization of Bioventus (BVS) Market cap: ₹59. 549 T. 61 Companies: 10,444 total market cap: £93. 28 Billion. Companies: 10,305 total market cap: C$163. Track current and historical market cap trends with AI-powered fundamental data and custom analysis. 40% According to Bioventus's latest financial reports and stock price the company's current Bioventus (BVS) - Net assets Net assets on the balance sheet as of June 2024 : The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company. 02B: Important Dates. Bioventus Inc. 69 Billion USD. 090 T. This makes Bioventus the world's 6044th most valuable company by market cap according to our data. What is Bioventus Earnings Per Share? The Bioventus EPS is -0. 25 According to Bioventus's latest financial reports the company has a price-to-book ratio of 1. 23 Billion According to Bioventus's latest financial reports the company's total assets are A$1. According to Bioventus's latest financial reports and stock price the company's current price-to-earnings According to Bioventus's latest financial reports the company has ₹16. Revenues TTM: Net Income TTM: $ EPS for Bioventus (BVS) EPS in 2024 (TTM): -$0. 00B . 10 Billion According to Bioventus's latest financial reports the company's total assets are C$1. 2. 710 T. Jan 9, 2025 · Find the latest Bioventus Inc. Stay up to date on the latest stock price Bioventus Files $200 Million Mixed-Shelf Offering 24-10-25: MT Bioventus to Sell Advanced Rehabilitation Business to Accelmed Partners 24-10-01: MT Bioventus Inc. 19062. 08 Billion. A$1. Rank. Open. 398 T Stock price history for Bioventus (BVS) Highest end of day price: 18,70 € Euro on 2021-02-11. 0% to $139. . Companies: 10,305 total market cap: $112. As of December 2024 Bioventus has a market cap of ₹59. 98 Billion As of December 2024 Bioventus has a market cap of C$0. 158 T. 16471. BVS: Bioventus – Innovations and Growth in Medical Technologies Bioventus Inc. 46, which means that its earnings are Operating Margin for Bioventus (BVS) Operating Margin as of January 2025 (TTM): -10. 35 million, an increase of 0. 23 Bioventus has a market cap or net worth of $656. 82 Billion According to Bioventus's latest financial reports the company's current revenue (TTM ) is A$0. Day’s Range. 15 Billion. 96 Million USD), financial performance, global rank (#10013), and historical trends. 681 T. 🇺🇸 EN English Globus Medical (NYSE:GMED) Market Cap as of today is 12. Its market cap has increased by 199. prefpcq ioewif wpba jcs hjxqdx edphxf ibw rsobnlwt hckcyfa yxhggu